SLC7A11 and ovarian carcinoma: Qin et al. (2023) also reported that SLC7A11 protein levels were significantly greater in cisplatin-resistant A2780/DDP and SKOV3/DDP ovarian cancer cell lines than in their cisplatin-sensitive counterparts.